Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Takahashi, N."" wg kryterium: Wszystkie pola


Tytuł:
Interleukin-23 levels in umbilical cord blood are associated with neurodevelopmental trajectories in infancy.
Autorzy:
Asaka MK; United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Suita, Japan.
Nishimura T; United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Suita, Japan.; Research Centre for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kuwabara H; Department of Psychiatry, Hamamatsu University School of Medicine, Hamamatsu, Japan.; Department of Psychiatry, Saitama Medical University, Moroyama-chou, Saitama, Japan.
Itoh H; Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Takahashi N; United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Suita, Japan.; Department of Child and Adolescent Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Tsuchiya KJ; United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Suita, Japan.; Research Centre for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 09; Vol. 19 (4), pp. e0301982. Date of Electronic Publication: 2024 Apr 09 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Fetal Blood*
Neurodevelopmental Disorders*
Infant, Newborn ; Infant ; Child ; Humans ; Child, Preschool ; Interleukin-23 ; Cytokines ; Umbilical Cord
Czasopismo naukowe
Tytuł:
Immediate postnatal prediction of death or bronchopulmonary dysplasia among very preterm and very low birth weight infants based on gradient boosting decision trees algorithm: A nationwide database study in Japan.
Autorzy:
Yoneda K; Department of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan.
Seki T; Department of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan.
Kawazoe Y; Department of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan.; Artificial Intelligence and Digital Twin in Healthcare, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Ohe K; Department of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan.; Department of Biomedical Informatics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Takahashi N; Department of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan.
Pokaż więcej
Corporate Authors:
Neonatal Research Network of Japan
Źródło:
PloS one [PLoS One] 2024 Mar 27; Vol. 19 (3), pp. e0300817. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Bronchopulmonary Dysplasia*/diagnosis
Bronchopulmonary Dysplasia*/epidemiology
Bronchopulmonary Dysplasia*/complications
Hypertension, Pulmonary*/complications
Premature Birth*
Infant ; Female ; Humans ; Infant, Newborn ; Pregnancy ; Japan/epidemiology ; Infant, Extremely Premature ; Infant, Very Low Birth Weight ; Gestational Age ; Decision Trees
Czasopismo naukowe
Tytuł:
Impact of COVID-19 versus other pneumonia on in-hospital mortality and functional decline among Japanese dialysis patients: a retrospective cohort study.
Autorzy:
Ikenouchi K; Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8519, Japan.; Department of Nephrology, Musashino Red Cross Hospital, 1-26-1, Kyonann-cho, Musashino-shi, Tokyo, 180-8610, Japan.
Takahashi D; Department of Nephrology, Musashino Red Cross Hospital, 1-26-1, Kyonann-cho, Musashino-shi, Tokyo, 180-8610, Japan.
Mandai S; Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8519, Japan. .
Watada M; Department of Nephrology, Musashino Red Cross Hospital, 1-26-1, Kyonann-cho, Musashino-shi, Tokyo, 180-8610, Japan.
Koyama S; Department of Nephrology, Musashino Red Cross Hospital, 1-26-1, Kyonann-cho, Musashino-shi, Tokyo, 180-8610, Japan.
Hoshino M; Department of Nephrology, Musashino Red Cross Hospital, 1-26-1, Kyonann-cho, Musashino-shi, Tokyo, 180-8610, Japan.
Takahashi N; Department of Nephrology, Musashino Red Cross Hospital, 1-26-1, Kyonann-cho, Musashino-shi, Tokyo, 180-8610, Japan.
Shoda W; Department of Nephrology, Musashino Red Cross Hospital, 1-26-1, Kyonann-cho, Musashino-shi, Tokyo, 180-8610, Japan.
Kuyama T; Department of Nephrology, Musashino Red Cross Hospital, 1-26-1, Kyonann-cho, Musashino-shi, Tokyo, 180-8610, Japan.
Mori Y; Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8519, Japan.
Ando F; Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8519, Japan.
Susa K; Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8519, Japan.
Mori T; Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8519, Japan.
Iimori S; Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8519, Japan.
Naito S; Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8519, Japan.
Sohara E; Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8519, Japan.
Fushimi K; Department of Health Policy and Informatics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8519, Japan.
Uchida S; Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8519, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 02; Vol. 14 (1), pp. 5177. Date of Electronic Publication: 2024 Mar 02.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
COVID-19*/epidemiology
Kidney Failure, Chronic*/epidemiology
Kidney Failure, Chronic*/therapy
Pneumonia*/epidemiology
Adult ; Humans ; Renal Dialysis ; Hospital Mortality ; Japan/epidemiology ; Retrospective Studies ; Pandemics
Czasopismo naukowe
Tytuł:
Suitable Patient Selection and Optimal Timing of Treatment for Persistent Air Leak after Lung Resection.
Autorzy:
Yamauchi Y; Department of Surgery, Teikyo University School of Medicine, Tokyo 173-8502, Japan.
Adachi H; Department of Thoracic Surgery, Kanagawa Cardiovascular and Respiratory Center, Yokohama 236-0051, Japan.
Takahashi N; Department of Thoracic Surgery, Saitama Cardiovascular and Respiratory Center, Kumagaya 360-0197, Japan.
Morohoshi T; Department of General Thoracic Surgery, Yokosuka Kyosai Hospital, Yokosuka 238-8558, Japan.
Yamamoto T; Department of Thoracic Surgery, Yokohama Rosai Hospital, Yokohama 222-0036, Japan.
Endo M; Department of Thoracic Surgery, Yamagata Prefectural Central Hospital, Yamagata 990-2292, Japan.
Ueno T; Department of Thoracic Surgery, National Hospital Organization Shikoku Cancer Center, Matsuyama 791-0245, Japan.
Woo T; Department of Surgery, Yokohama City University, Yokohama 236-0004, Japan.
Saito Y; Department of Surgery, Teikyo University School of Medicine, Tokyo 173-8502, Japan.
Sawabata N; Department of Thoracic and Cardiovascular Surgery, Nara Medical University, Kashihara 634-8521, Japan.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2024 Feb 19; Vol. 13 (4). Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Journal Article
Czasopismo naukowe
Czasopismo naukowe
Tytuł:
A girl with Down syndrome and partial trisomy for 21pter‐q22.13: A clue to narrow the Down syndrome critical regionHow to cite this article: Sato D, Kawara H, Shimokawa O, Harada N, Tonoki H, Takahashi N, Imai Y, Kimura H, Matsumoto N, Ariga T, Niikawa N, Yoshiura K. 2007. A girl with Down syndrome and partial trisomy for 21pter‐q22.13: A clue to narrow the Down syndrome critical region. Am J Med Genet Part A 146A:124–127.
Autorzy:
Sato, Daisuke
Kawara, Hiroki
Shimokawa, Osamu
Harada, Naoki
Tonoki, Hidefumi
Takahashi, Nobuhiro
Imai, Yumi
Kimura, Hiromi
Matsumoto, Naomichi
Ariga, Tadashi
Niikawa, Norio
Yoshiura, Koh‐ichiro
Pokaż więcej
Źródło:
American Journal of Medical Genetics. Part A; January 2008, Vol. 146 Issue: 1 p124-127, 4p
Periodyk
Tytuł:
Multidisciplinary pain management program for patients with chronic musculoskeletal pain in Japan: a cohort study
Autorzy:
Takahashi N
Takatsuki K
Kasahara S
Yabuki S
Pokaż więcej
Temat:
chronic musculoskeletal pain
multidisciplinary pain treatment
biopsychosocial model
inpatient pain management program
Medicine (General)
R5-920
Źródło:
Journal of Pain Research, Vol Volume 12, Pp 2563-2576 (2019)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/multidisciplinary-pain-management-program-for-patients-with-chronic-mu-peer-reviewed-article-JPR; https://doaj.org/toc/1178-7090
Dostęp URL:
https://doaj.org/article/119e37e19e9f4910adccc2625da5d83b  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Asciminib vs bosutinib in CML patients pretreated with ≥2 tyrosine kinase inhibitors: Results from the Japanese subgroup analysis of ASCEMBL study.
Autorzy:
Yuda J; National Cancer Center Hospital East, Chiba, Japan.
Doki N; Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Matsuoka H; Kobe University Hospital, Kobe, Japan.
Yokota T; Osaka University Hospital, Osaka, Japan.
Tomita A; Fujita Health University School of Medicine, Toyoake, Japan.
Takahashi N; Akita University Hospital, Akita, Japan.
Matsumura I; Kindai University Hospital, Osaka, Japan.
Kubo K; Aomori Prefectural Central Hospital, Aomori, Japan.
Goto T; Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
Kirito K; University of Yamanashi Hospital, Yamanashi, Japan.
Maki A; Novartis Pharma KK, Tokyo, Japan.
Aoki M; Novartis Pharma KK, Tokyo, Japan.
Allepuz A; Novartis Pharma AG, Basel, Switzerland.
Minami Y; National Cancer Center Hospital East, Chiba, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (3), pp. 2990-2998. Date of Electronic Publication: 2022 Sep 27.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Leukemia, Myeloid, Chronic-Phase*/drug therapy
Humans ; Tyrosine Kinase Inhibitors ; Fusion Proteins, bcr-abl ; East Asian People ; Protein Kinase Inhibitors/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies